<DOC>
	<DOCNO>NCT00797992</DOCNO>
	<brief_summary>To evaluate clinical result anti-VEGF intra-vitreal injection ( IVT ) CNV secondary pathologic myopia ( PM-CNV ) .</brief_summary>
	<brief_title>Bevacizumab Intravitreal Myopic Choroidal Neovascularization</brief_title>
	<detailed_description>Nineteen consecutive patient ( 19 eye ) subfoveal PM-CNV , 18 unsuccessfully treat Visudyne PDT , treat IVT 1.25 mg bevacizumab 0.5mg ranibizumab . ETDRS best correct visual acuity , macular thickness OCT scan , angiographic feature record evaluate . The aspect OCT scan pass across PM-CNV also analyze . IVTs repeat case persistent angiographic leakage OCT scan show retinal thickening edema serous retinal detachment . The follow-up period least 6 month .</detailed_description>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Myopic CNVM , Patients poor compliance Patients uncontrolled diabetes hypertension medical condition increase risk complication like recent history Stroke myocardial infraction ( &lt; one year ) . ( Physician clearance obtain patient ) . Age relate macular degeneration Juxtafoveal Subfoveal CNVM : Recurrent CNVM follow PDT TTT IVTA . Patient could afford PDT , Macugen Lucentis FDA approve . Patients undergone major surgery 28 day , exclude study also suspend prior elective surgery . Refractory macular oedema due vein occlusion , Pseudophakia , Clinically significant macular oedema ( CSME ) etc . affect vision respond adequately usual treatment method . Proliferative diabetic retinopathy , nonresolving vitreous haemorrhage PDR . Idiopathic CNVM , Inflammatory CNVM condition associate CNVM .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Bevacizumab</keyword>
	<keyword>Myopia</keyword>
	<keyword>Complications</keyword>
	<keyword>Neovascularization</keyword>
	<keyword>OCT</keyword>
</DOC>